51 related articles for article (PubMed ID: 32557926)
1. Successful Treatment of Lichen Planus With Oral Upadacitinib.
Zundell MP; Kaminetsky J; Lebwohl M; Gottlieb AB
J Drugs Dermatol; 2023 Oct; 22(10):1058-1060. PubMed ID: 37801537
[TBL] [Abstract][Full Text] [Related]
2. Nail lichen planus treatment safety.
Axler EN; Lipner SR
Expert Opin Drug Saf; 2023; 22(12):1157-1168. PubMed ID: 38014463
[TBL] [Abstract][Full Text] [Related]
3. Reticular lacy lichen planus of penis.
Madke B; Sood N
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38110344
[No Abstract] [Full Text] [Related]
4. Addisonian-like acrofacial hyperpigmentation following long-term hydroxychloroquine therapy in oral lichen planus.
Bhanja DB; Sil A; Chandra A; Biswas SK
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509894
[No Abstract] [Full Text] [Related]
5. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients.
Dheir H; Sipahi S; Yaylacı S; Çetin ES; Genç AB; Fırat N; Köroğlu M; Muratdağı G; Tomak Y; Özmen K; Ateş ÖF; Karabay O
Turk J Med Sci; 2021 Apr; 51(2):428-434. PubMed ID: 33185367
[TBL] [Abstract][Full Text] [Related]
6. Risk of serious infection, malignancy, or death in Japanese rheumatoid arthritis patients treated with a combination of abatacept and tacrolimus: a retrospective cohort study.
Tokunaga K; Matsui K; Oshikawa H; Matsui T; Tohma S
Clin Rheumatol; 2021 May; 40(5):1811-1817. PubMed ID: 33123921
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in lung transplant recipients: A multicenter study.
Saez-Giménez B; Berastegui C; Barrecheguren M; Revilla-López E; Los Arcos I; Alonso R; Aguilar M; Mora VM; Otero I; Reig JP; Quezada CA; Pérez V; Valle M; Laporta R; Deu M; Sacanell J; Bravo C; Gavalda J; Lopez-Meseguer M; Monforte V
Am J Transplant; 2021 May; 21(5):1816-1824. PubMed ID: 33089648
[TBL] [Abstract][Full Text] [Related]
8. Erythema dyschromicum perstans in an infant with positive Darier sign: A case report successfully treated with tacrolimus.
Ercan N
Dermatol Ther; 2020 Nov; 33(6):e14175. PubMed ID: 32779368
[No Abstract] [Full Text] [Related]
9. Moyamoya syndrome related to systemic lupus erythematosus developing during pregnancy: a case-based review.
Tanaka R; Shimojima Y; Ueno KI; Takasone K; Ichikawa T; Kishida D; Sekijima Y
Clin Rheumatol; 2020 Dec; 39(12):3861-3867. PubMed ID: 32562069
[TBL] [Abstract][Full Text] [Related]
10. Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients.
Ujiie H; Nihei S; Nishiya N; Goto S; Asakura Y; Miura S; Hirai D; Endo M; Oyake T; Ito S; Chiba T; Kudo K
Anticancer Res; 2021 May; 41(5):2591-2596. PubMed ID: 33952488
[TBL] [Abstract][Full Text] [Related]
11. Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic.
Souaid K; Klejtman T; Kramkimel N; Isnard C; Dupin N; Aractingi S
Ann Dermatol Venereol; 2021 Jun; 148(2):122-123. PubMed ID: 33551212
[No Abstract] [Full Text] [Related]
12. Low-dose tacrolimus in treating neuromyelitis optica spectrum disorder.
Wang L; Tan H; Huang W; ZhangBao J; Chang X; Zhou L; Lu C; Wang M; Lu J; Zhao C; Quan C
Mult Scler Relat Disord; 2021 Feb; 48():102707. PubMed ID: 33383362
[TBL] [Abstract][Full Text] [Related]
13. Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single Institution.
Iino M; Sato T; Sakamoto Y
Transplant Proc; 2021; 53(1):396-404. PubMed ID: 33308840
[TBL] [Abstract][Full Text] [Related]
14. Occlusive treatment enhances efficacy of tacrolimus 0.1% in a pediatric patient with severe alopecia areata: Case report and literature review.
Bimbi C; Kyriakou G; Wollina U
Pediatr Dermatol; 2021 Jan; 38(1):339-340. PubMed ID: 33247446
[TBL] [Abstract][Full Text] [Related]
15. Adherence in pediatric renal recipients and its effect on graft outcome, a single-center, retrospective study.
Feddersen N; Pape L; Beneke J; Brand K; Prüfe J
Pediatr Transplant; 2021 May; 25(3):e13922. PubMed ID: 33227161
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplant.
Cenin DA; Freyer CW; Ligon CB; Luger SM; McCurdy SR; Martin ME; Frey NV
J Oncol Pharm Pract; 2021 Apr; 27(3):771-775. PubMed ID: 32819196
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study.
Kanokrungsee S; Pruettivorawongse D; Rajatanavin N
J Cosmet Dermatol; 2021 Mar; 20(3):812-818. PubMed ID: 32744369
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of topical tacrolimus and topical triamcinolone acetonide in nodular scabies.
Manjhi M; Yadav P; Mohan S; Sonthalia S; Ramesh V; Kashyap V
Dermatol Ther; 2020 Nov; 33(6):e13954. PubMed ID: 32621663
[TBL] [Abstract][Full Text] [Related]
19. Lichen planus actinicus treated successfully with topical tacrolimus 0.1%: A report of six cases.
Kemeriz F; Acar EM; Ordu M; Kilitçi A
Dermatol Ther; 2020 Nov; 33(6):e13882. PubMed ID: 32557926
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
